Evidence map›Paper›PMID 32277988›Full record

ArticleJournal of molecular biology2020

A Generalizable Optogenetic Strategy to Regulate Receptor Tyrosine Kinases during Vertebrate Embryonic Development.

Vishnu V Krishnamurthy, Jia Fu, Teak-Jung Oh, John Khamo, Jing Yang, Kai Zhang

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Optogenetic engineering for ion channel modulation.Current opinion in chemical biology · 2025
    Review
  7. Review
  8. Optogenetic clustering and membrane translocation of the BcLOV4 photoreceptor.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vishnu V KrishnamurthyDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Jia FuDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Teak-Jung OhDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
John KhamoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Jing YangDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA. Electronic address: yangj@illinois.edu.
Kai ZhangDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. Electronic address: kaizkaiz@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

Research Training Program in Toxicology and Environmental HealthT32ES007326 · NIEHS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Jodi A. Flaws · 2000 to 2026
$8.7M
Maternal control of germline developmentR35GM131810 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Jing Yang · 2019 to 2026
$3.2M
Mechanism of Gp1 mGluR-dependent translation and plasticityR01MH124827 · NIMH · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI TSAI, NIEN-PEI, ZHANG, KAI · 2021 to 2025
$2.3M
Precise regulation of native transcription factor at the single-cell levelR01GM132438 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ZHANG, KAI · 2019 to 2022
$1.4M
NIEHS NIH HHS T32 ES007326NIGMS NIH HHS R01 GM132438NIGMS NIH HHS R35 GM131810NIMH NIH HHS R01 MH124827
6 · The paper itself

Abstract

Ligand-independent activation of receptor tyrosine kinases (RTKs) allows for dissecting out the receptor-specific signaling outcomes from the pleiotropic effects of the ligands. In this regard, RTK intracellular domains (ICD) are of interest due to their ability to recapitulate signaling activity in a ligand-independent manner when fused to chemical or optical dimerizing domains. A common strategy for synthetic activation of RTKs involves membrane tethering of dimerizer-RTK ICD fusions. Depending on the intrinsic signaling capacity, however, this approach could entail undesirable baseline signaling activity in the absence of stimulus, thereby diminishing the system's sensitivity. Here, we observed toxicity in early Xenopus laevis embryos when using such a conventional optogenetic design for the fibroblast growth factor receptor (FGFR). To surpass this challenge, we developed a cytoplasm-to-membrane translocation approach, where FGFR ICD is recruited from the cytoplasm to the plasma membrane by light, followed by its subsequent activation via homo-association. This strategy results in the optical activation of FGFR with low background activity and high sensitivity, which allows for the light-mediated formation of ectopic tail-like structures in developing X. laevis embryos. We further generalized this strategy by developing optogenetic platforms to control three neurotrophic tropomyosin receptor kinases, TrkA, TrkB, and TrkC. We envision that these ligand-independent optogenetic RTKs will provide useful toolsets for the delineation of signaling sub-circuits in developing vertebrate embryos.

Indexed as

AnimalsCell MembraneCytoplasmEmbryonic DevelopmentHEK293 CellsHumansOptogeneticsProtein TransportReceptor Protein-Tyrosine KinasesSignal TransductionXenopus laevisXenopus ProteinsReceptor Protein-Tyrosine KinasesXenopus Proteinsdifferentiationectopic tailoptogeneticsRTK signalingXenopus laevis

Identifiers

PMID32277988
PMCPMC7254881
OpenAlexW3015830740

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.